Dr Reddy’s launch Fluphenazine Hydrochloride Tablets in US

Fluphenazine hydrochloride is a trifluoromethyl phenothiazine derivative intended for the management of schizophrenia

Dr Reddy’s Laboratories announced the launch of Fluphenazine Hydrochloride Tablets, USP,a therapeutic equivalent generic version of Prolixin Tablets, 1mg, 2.5mg, 5mg, and 10mg, approved by the US Food and Drug Administration (USFDA).

Fluphenazine hydrochloride is a trifluoromethyl phenothiazine derivative intended for the management of schizophrenia.

The Prolixin brand and generic had U.S. sales of approximately $134 million MAT for the most recent twelve months ending in December 2020 according to IQVIA Health.

Dr Reddy’s Fluphenazine Hydrochloride Tablets, USP are available in 1mg, 2.5mg, 5mg, and 10mg tablets in 100 bottle count sizes.

 

 

Dr Reddy's LaboratoriesFluphenazine Hydrochloride TabletsSchizophreniaUS Pharma marketUSFDA
Comments (0)
Add Comment